{"id":"W4389685271","doi":"10.1038/s41591-023-02679-9","title":"Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health; St. Jude Medical; Assistance publique-Hôpitaux de Paris; MyoKardia; Innovationsfonden; Boston VA Research Institute; Regado Biosciences; Wellcome Trust; Cleveland Clinic; Boston Scientific Corporation; Duke Clinical Research Institute; Novo Nordisk; American Heart Association; Daiichi Sankyo Europe; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Proarrhythmia; Atrial fibrillation; Cardioversion; Clinical endpoint; Placebo; Randomized controlled trial; Adverse effect; Anesthesia; Sinus rhythm; Internal medicine; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002752268,0.00227107,0.002839079,0.0004295928,0.0004393625,0.001407749,0.0006594427,0.002310337,0.007629997],"category_scores_gemma":[0.002662686,0.0006273949,0.001737747,0.0004459856,0.001022722,0.001177044,0.0004060626,0.002627284,0.001018464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005376516,"about_ca_system_score_gemma":0.0009920771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004209063,"about_ca_topic_score_gemma":0.0007392112,"domain_scores_codex":[0.9988218,0.0007206043,0.00006855791,0.0001755347,0.00008681058,0.000126706],"domain_scores_gemma":[0.9988773,0.0004192147,0.0002492314,0.00008656556,0.00009077705,0.0002769184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9822754,0.003734449,0.0005512406,0.0006715034,0.0008291137,0.00006279897,0.00003224901,0.0003386292,0.001949684,0.0001804146,0.001248937,0.008125583],"study_design_scores_gemma":[0.9791413,0.0189146,0.0005807208,0.00002958291,0.0002745456,0.00002392209,0.000007341373,0.000308276,0.0001539982,0.0001312942,0.0004260911,0.000008348979],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678507,0.008996591,0.00208332,0.002441578,0.001782982,0.01007195,0.002456041,0.0002435045,0.004073263],"genre_scores_gemma":[0.9686273,0.003980665,0.002786743,0.002924311,0.001455707,0.01389286,0.00191453,0.00004883046,0.004368981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007629997,"threshold_uncertainty_score":0.02552485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03903936154391102,"score_gpt":0.362225024930335,"score_spread":0.323185663386424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}